← Back to Search

Training Programs for Autism (TEAMS Trial)

N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up attendance will be tracked throughout intervention training and compiled at post intervention (6 months)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a training program called TEAMS, which uses Motivational Interviewing strategies, can help providers implement evidence-based interventions for children with autism spectrum disorder more effectively.

Who is the study for?
This trial is for leaders, providers, and parents involved in mental health programs or public education services for children with Autism Spectrum Disorder (ASD) in certain California counties. Leaders must manage enrolled sites; providers need an eligible child on their caseload and commit to at least 7 months of employment; parents are paired with participating providers.
What is being tested?
The study tests the TEAMS model's effectiveness in improving ASD interventions. It combines Team-Enhanced Teams Leadership Institute (TLI) training for leaders and Motivational Interviewing strategies (TIPS) for providers, alongside AIM HI intervention in mental health settings or CPRT intervention in schools.
What are the potential side effects?
Since this trial focuses on educational and behavioral strategies rather than medical treatments, traditional side effects like those seen with medications are not applicable. However, participants may experience stress or discomfort during new training methods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~attendance will be tracked throughout intervention training and compiled at post intervention (6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and attendance will be tracked throughout intervention training and compiled at post intervention (6 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Provider Training Completion / Certification
Secondary study objectives
Child Improvements on The Eyberg Child Behavior Inventory (ECBI)
Child Improvements on the PDD Behavior Inventory, Parent Extended Version (PDDBI-PX)
Other study objectives
Evidence-Based Practice Attitude Scale (EBPAS-15)
Implementation Climate Scales
Implementation Leadership Scales
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: TIPS + TLIExperimental Treatment4 Interventions
Programs assigned to the TIPS + TLI condition will receive TIPS EBI training for providers and leaders will participate in TLI
Group II: TEAMS Leadership Institute (TLI) ONLYExperimental Treatment4 Interventions
Programs assigned to the TLI ONLY condition will receive standard EBI training for providers and leaders will participate in TLI.
Group III: Motivational Enhancement (TIPS for Training) ONLYExperimental Treatment3 Interventions
Programs assigned to the TIPS ONLY condition will receive enhanced TIPS EBI training for providers.
Group IV: StandardActive Control2 Interventions
Programs assigned to the Standard condition will receive standard EBI training only

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
943 Previous Clinical Trials
4,754,482 Total Patients Enrolled
14 Trials studying Autism Spectrum Disorder
4,695 Patients Enrolled for Autism Spectrum Disorder
University of California, San DiegoOTHER
1,180 Previous Clinical Trials
1,573,850 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
13,739 Patients Enrolled for Autism Spectrum Disorder
University of California, Los AngelesOTHER
1,564 Previous Clinical Trials
10,261,427 Total Patients Enrolled
25 Trials studying Autism Spectrum Disorder
3,193 Patients Enrolled for Autism Spectrum Disorder
~337 spots leftby Aug 2027